I spoke with Jean today in FIRST's offices. She had recently spoken with the president of the company responsible for these Liarozole trials and was told the following:
We are not recruiting in the USA since the FDA did not allow us to start the clinical program in this country. We are recruiting in 8 other countries including Canada . We have currently about 50 patients with lamellar ichthyosis in our study. We need a total of 98. Any help through you can give through your international contacts would of course be appreciated.
Jean said it would be alright for me to share that with all of you--and I knew folks would appreciate hearing that additional information--so now you have it! (Many thanks, Jean!)
[This message has been edited by Laura Phillips (edited September 12, 2006).]